Dietary supplement for men with HPV infection
Part of Infections clinical trials.
This trial tests whether a daily supplement with green tea extract (EGCG), vitamin B12, hyaluronic acid, and folic acid can help the body's natural defenses fight HPV infection in men. It may be useful for couples trying to conceive where the male partner has an active HPV infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 25 and 65 years old.
- You and your partner are trying to get pregnant.
- You have an active HPV infection (confirmed by a DNA test).
- Your female partner does not have an HPV infection (confirmed by a DNA test).
- You are not currently taking any immune-suppressing medications or green tea extracts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily supplement (with green tea extract, folic acid, and vitamins) can help clear HPV in men and support genital health. It is designed for couples trying to conceive, where only the male has an active HPV infection.
This study tests whether a daily supplement with green tea extract, folic acid, vitamin B12, and hyaluronic acid can help clear a persistent HPV infection and prevent cervical lesions from getting worse. It may be an option for people who have had a low-grade cervical lesion and have already been vaccinated against HPV.
This trial tests whether taking a combination of EGCG (a compound from green tea), folic acid, and vitamin B12 can help prevent an HPV infection from lasting or getting worse. You may be able to join if you have a high-risk HPV infection but not a more serious cervical cell change called HSIL.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.